COVID-DSNet: A novel deep convolutional neural network for detection of coronavirus (SARS-CoV-2) cases from CT and Chest X-Ray images

Deep Learning for Pneumonia Detection in Chest X-ray Images: A Comprehensive Survey

This paper addresses the significant problem of identifying the relevant background and contextual literature related to deep learning (DL) as an evolving technology in order to provide a comprehensive analysis of the application of DL to the specific problem of pneumonia detection via chest X-ray (CXR) imaging, which is the most common and cost-effective imaging technique available worldwide for pneumonia diagnosis. This paper in particular addresses the key period associated with COVID-19, 2020-2023, to explain, analyze, and systematically evaluate the limitations of approaches and determine their relative levels of effectiveness. The context in which DL is applied as both an aid to and an automated substitute for existing expert radiography professionals, who often have limited availability, is elaborated in detail. The rationale for the undertaken research is provided, along with a justification of the resources adopted and their relevance. This explanatory text and the subsequent analyses are intended to provide sufficient detail of the problem being addressed, existing solutions, and the limitations of these, ranging in detail from the specific to the more general. Indeed, our analysis and evaluation agree with the generally held view that the use of transformers, specifically, vision transformers (ViTs), is the most promising technique for obtaining further effective results in the area of pneumonia detection using CXR images. However, ViTs require extensive further research to address several limitations, specifically the following: biased CXR datasets, data and code availability, the ease with which a model can be explained, systematic methods of accurate model comparison, the notion of class imbalance in CXR datasets, and the possibility of adversarial attacks, the latter of which remains an area of fundamental research.

Artificial intelligence-assisted diagnosis of congenital heart disease and associated pulmonary arterial hypertension from chest radiographs: A multi-reader multi-case study

OBJECTIVES

To explore the possibility of automatic diagnosis of congenital heart disease (CHD) and pulmonary arterial hypertension associated with CHD (PAH-CHD) from chest radiographs using artificial intelligence (AI) technology and to evaluate whether AI assistance could improve clinical diagnostic accuracy.

MATERIALS AND METHODS

A total of 3255 frontal preoperative chest radiographs (1174 CHD of any type and 2081 non-CHD) were retrospectively obtained. In this study, we adopted ResNet18 pretrained with the ImageNet database to establish diagnostic models. Radiologists diagnosed CHD/PAH-CHD from 330/165 chest radiographs twice: the first time, 50% of the images were accompanied by AI-based classification; after a month, the remaining 50% were accompanied by AI-based classification. Diagnostic results were compared between the radiologists and AI models, and between radiologists with and without AI assistance.

RESULTS

The AI model achieved an average area under the receiver operating characteristic curve (AUC) of 0.948 (sensitivity: 0.970, specificity: 0.982) for CHD diagnoses and an AUC of 0.778 (sensitivity: 0.632, specificity: 0.925) for identifying PAH-CHD. In the 330 balanced (165 CHD and 165 non-CHD) testing set, AI achieved higher AUCs than all 5 radiologists in the identification of CHD (0.670-0.858) and PAH-CHD (0.610-0.688). With AI assistance, the mean ± standard error AUC of radiologists was significantly improved for CHD (ΔAUC + 0.096, 95 % CI: 0.001-0.190; P = 0.048) and PAH-CHD (ΔAUC + 0.066, 95 % CI: 0.010-0.122; P = 0.031) diagnosis.

CONCLUSION

Chest radiograph-based AI models can detect CHD and PAH-CHD automatically. AI assistance improved radiologists' diagnostic accuracy, which may facilitate a timely initial diagnosis of CHD and PAH-CHD.

Stacked deep learning approach for efficient SARS-CoV-2 detection in blood samples

Identifying COVID-19 through blood sample analysis is crucial in managing the disease and improving patient outcomes. Despite its advantages, the current test demands certified laboratories, expensive equipment, trained personnel, and 3-4 h for results, with a notable false-negative rate of 15%-20%. This study proposes a stacked deep-learning approach for detecting COVID-19 in blood samples to distinguish uninfected individuals from those infected with the virus. Three stacked deep learning architectures, namely the StackMean, StackMax, and StackRF algorithms, are introduced to improve the detection quality of single deep learning models. To counter the class imbalance phenomenon in the training data, the Synthetic Minority Oversampling Technique (SMOTE) algorithm is also implemented, resulting in increased specificity and sensitivity. The efficacy of the methods is assessed by utilizing blood samples obtained from hospitals in Brazil and Italy. Results revealed that the StackMax method greatly boosted the deep learning and traditional machine learning methods' capability to distinguish COVID-19-positive cases from normal cases, while SMOTE increased the specificity and sensitivity of the stacked models. Hypothesis testing is performed to determine if there is a significant statistical difference in the performance between the compared detection methods. Additionally, the significance of blood sample features in identifying COVID-19 is analyzed using the XGBoost (eXtreme Gradient Boosting) technique for feature importance identification. Overall, this methodology could potentially enhance the timely and precise identification of COVID-19 in blood samples.

Optimizing Gene Selection and Cancer Classification with Hybrid Sine Cosine and Cuckoo Search Algorithm

Gene expression datasets offer a wide range of information about various biological processes. However, it is difficult to find the important genes among the high-dimensional biological data due to the existence of redundant and unimportant ones. Numerous Feature Selection (FS) techniques have been created to get beyond this obstacle. Improving the efficacy and precision of FS methodologies is crucial in order to identify significant genes amongst complicated complex biological data. In this work, we present a novel approach to gene selection called the Sine Cosine and Cuckoo Search Algorithm (SCACSA). This hybrid method is designed to work with well-known machine learning classifiers Support Vector Machine (SVM). Using a dataset on breast cancer, the hybrid gene selection algorithm's performance is carefully assessed and compared to other feature selection methods. To improve the quality of the feature set, we use minimum Redundancy Maximum Relevance (mRMR) as a filtering strategy in the first step. The hybrid SCACSA method is then used to enhance and optimize the gene selection procedure. Lastly, we classify the dataset according to the chosen genes by using the SVM classifier. Given the pivotal role gene selection plays in unraveling complex biological datasets, SCACSA stands out as an invaluable tool for the classification of cancer datasets. The findings help medical practitioners make well-informed decisions about cancer diagnosis and provide them with a valuable tool for navigating the complex world of gene expression data.

A Systematic Review on Deep Structured Learning for COVID-19 Screening Using Chest CT from 2020 to 2022

The emergence of the COVID-19 pandemic in Wuhan in 2019 led to the discovery of a novel coronavirus. The World Health Organization (WHO) designated it as a global pandemic on 11 March 2020 due to its rapid and widespread transmission. Its impact has had profound implications, particularly in the realm of public health. Extensive scientific endeavors have been directed towards devising effective treatment strategies and vaccines. Within the healthcare and medical imaging domain, the application of artificial intelligence (AI) has brought significant advantages. This study delves into peer-reviewed research articles spanning the years 2020 to 2022, focusing on AI-driven methodologies for the analysis and screening of COVID-19 through chest CT scan data. We assess the efficacy of deep learning algorithms in facilitating decision making processes. Our exploration encompasses various facets, including data collection, systematic contributions, emerging techniques, and encountered challenges. However, the comparison of outcomes between 2020 and 2022 proves intricate due to shifts in dataset magnitudes over time. The initiatives aimed at developing AI-powered tools for the detection, localization, and segmentation of COVID-19 cases are primarily centered on educational and training contexts. We deliberate on their merits and constraints, particularly in the context of necessitating cross-population train/test models. Our analysis encompassed a review of 231 research publications, bolstered by a meta-analysis employing search keywords (COVID-19 OR Coronavirus) AND chest CT AND (deep learning OR artificial intelligence OR medical imaging) on both the PubMed Central Repository and Web of Science platforms.

Diagnosis of COVID-19 from X-rays using combined CNN-RNN architecture with transfer learning

Combating the COVID-19 pandemic has emerged as one of the most promising issues in global healthcare. Accurate and fast diagnosis of COVID-19 cases is required for the right medical treatment to control this pandemic. Chest radiography imaging techniques are more effective than the reverse-transcription polymerase chain reaction (RT-PCR) method in detecting coronavirus. Due to the limited availability of medical images, transfer learning is better suited to classify patterns in medical images. This paper presents a combined architecture of convolutional neural network (CNN) and recurrent neural network (RNN) to diagnose COVID-19 patients from chest X-rays. The deep transfer techniques used in this experiment are VGG19, DenseNet121, InceptionV3, and Inception-ResNetV2, where CNN is used to extract complex features from samples and classify them using RNN. In our experiments, the VGG19-RNN architecture outperformed all other networks in terms of accuracy. Finally, decision-making regions of images were visualized using gradient-weighted class activation mapping (Grad-CAM). The system achieved promising results compared to other existing systems and might be validated in the future when more samples would be available. The experiment demonstrated a good alternative method to diagnose COVID-19 for medical staff. 

All the data used during the study are openly available from the Mendeley data repository at https://data.mendeley.com/datasets/mxc6vb7svm. For further research, we have made the source code publicly available at https://github.com/Asraf047/COVID19-CNN-RNN.

A novel discrete learning-based intelligent methodology for breast cancer classification purposes

Classification is one of the most significant subfields of data mining that has been successfully applied to various applications. The literature has expended substantial effort to present more efficient and accurate classification models. Despite the diversity of the proposed models, they were all created using the same methodology, and their learning processes ignored a fundamental issue. In all existing classification model learning processes, a continuous distance-based cost function is optimized to estimate the unknown parameters. The classification problem's objective function is discrete. Consequently, applying a continuous cost function to a classification problem with a discrete objective function is illogical or inefficient. This paper proposes a novel classification methodology utilizing a discrete cost function in the learning process. To this end, one of the most popular intelligent classification models, the multilayer perceptron (MLP), is used to implement the proposed methodology. Theoretically, the classification performance of the proposed discrete learning-based MLP (DIMLP) model is not dissimilar to that of its continuous learning-based counterpart. Nevertheless, in this study, to demonstrate the efficacy of the DIMLP model, it was applied to several breast cancer classification datasets, and its classification rate was compared to that of the conventional continuous learning-based MLP model. The empirical results indicate that the proposed DIMLP model outperforms the MLP model across all datasets. The results demonstrate that the presented DIMLP classification model achieves an average classification rate of 94.70 %, a 6.95 % improvement over the classification rate of the traditional MLP model, which was 88.54 %. Therefore, the classification approach proposed in this study can be utilized as an alternative learning process in intelligent classification methods for medical decision-making and other classification applications, particularly when more accurate results are required.